BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16818170)

  • 1. Clinical manifestations and management of neurofibromatosis type 1.
    Tonsgard JH
    Semin Pediatr Neurol; 2006 Mar; 13(1):2-7. PubMed ID: 16818170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognizing an index case of type 1 neurofibromatosis.
    Pollack CV; Pender ES
    Am Fam Physician; 1992 Feb; 45(2):623-8. PubMed ID: 1739047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis. Clinical overview.
    Brill CB
    Clin Orthop Relat Res; 1989 Aug; (245):10-5. PubMed ID: 2502339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imaging features of neurofibromatosis type 1].
    Jacques C; Dietemann JL
    J Neuroradiol; 2005 Jun; 32(3):180-97. PubMed ID: 16134300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmental neurofibromatosis and malignancy.
    Dang JD; Cohen PR
    Skinmed; 2010; 8(3):156-9. PubMed ID: 21137621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous clinical management of patients with neurofibromatosis type 1].
    Ohno K
    Nihon Rinsho; 2010 Jan; 68(1):131-5. PubMed ID: 20077805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral spinal neurofibromas in patients with neurofibromatosis 1.
    Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J; Velazquez-Fragua R; López-Gutierrez JC
    Brain Dev; 2012 Aug; 34(7):563-9. PubMed ID: 21999966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
    De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
    Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachial plexopathy due to malignant peripheral nerve sheath tumor in neurofibromatosis type 1: case report and subject review.
    Pacelli J; Whitaker CH
    Muscle Nerve; 2006 May; 33(5):697-700. PubMed ID: 16323217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
    Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
    Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
    Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
    Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis.
    Roos KL; Muckway M
    Dermatol Clin; 1995 Jan; 13(1):105-11. PubMed ID: 7712636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliomas in patients with neurofibromatosis type 1.
    Albers AC; Gutmann DH
    Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.